Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | SNCA | P37840 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | TYR | P14679 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29727537 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL343784 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL28222024 | 0.98 | MAPT (0.97) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL7573821 | 0.86 | ALDH1A1 (0.76) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL29886427 | 0.86 | ALDH1A1 (0.76) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL9120628 | 0.85 | APP (0.76) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL9120636 | 0.85 | APP (0.76) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL27736560 | 0.85 | ALDH1A1 (0.73) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL11823438 | 0.83 | MAPT (0.71) | ALDH1A1MAPTKDM4EMEN1TP53 | |
| SCHEMBL544907 | 0.83 | MAPT (0.71) | ALDH1A1MAPTKDM4EMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025049554-A1 | HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES | NEW YORK UNIVERSITY (US) | 2025-03-06 | — | — | WO | claimed |
| WO-2009091889-A1 | TREATMENT OF SKIN DISORDERS WITH EGFR INHIBITORS | GEORGETOWN UNIVERSITY (US) | 2009-07-23 | — | — | WO | claimed |
| EP-0809493-B1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | US HEALTH (US) | 2002-09-11 | — | — | EP | claimed |
| EP-0809493-A1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-12-03 | — | — | EP | claimed |
| US-5610185-A | Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-03-11 | — | — | US | claimed |
| WO-1996025159-A1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-08-22 | — | — | WO | claimed |
| US-3998851-A | PREPARATION OF COUMARINS | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-12-21 | — | — | US | claimed |
| JP-3109323-A | — | — | None | — | — | JP | disclosed |
| WO-2026087699-A1 | NEW TREATMENT OF NON-SMALL CELL LUNG CANCER | PIERRE FABRE MEDICAMENT (FR) | 2026-04-30 | — | — | WO | disclosed |
| EP-4578457-A1 | PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER | Toray Industries, Inc. (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-20250075218-A1 | HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES | NEW YORK UNIVERSITY (US) | 2025-03-06 | — | — | US | disclosed |
| WO-2025049554-A1 | HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES | NEW YORK UNIVERSITY (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20240309327-A1 | CARDIOMYOCYTE PRODUCTION METHOD | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-19 | — | — | US | disclosed |
| WO-1996025949-A1 | COMPOUNDS FOR PREVENTING MULTIDRUG RESISTANCE IN CANCER CELLS CONTAINING PROTEIN KINASE INHIBITORS | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1996-08-29 | — | — | WO | disclosed |
| EP-0728009-A1 | USE OF AN AGENT WHICH MODULATES TYROSINE PHOSPHORYLATION FOR MODULATING THE PERMEABILITY OF A PSYCHOLOGICAL BARRIER | Eisai Co., Ltd. (JP) | 1996-08-28 | — | — | EP | disclosed |
| WO-1996025159-A1 | A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-08-22 | — | — | WO | disclosed |
| WO-1996018103-A1 | INHIBITION OF GLIAL CELL PROLIFERATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-06-13 | — | — | WO | disclosed |
| WO-1995013820-A1 | USE OF AN AGENT WHICH MODULATES TYROSINE PHOSPHORYLATION FOR MODULATING THE PERMEABILITY OF A PSYCHOLOGICAL BARRIER | EISAI CO., LTD. (JP) | 1995-05-26 | — | — | WO | disclosed |
| JP-H03109323-A | ANTICANCER AGENT | MICROBIAL CHEM RES FOUND | 1991-05-09 | — | — | JP | disclosed |
| US-3998851-A | PREPARATION OF COUMARINS | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-12-21 | — | — | US | disclosed |